The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

Thu, 30th Apr 2020 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

ODDO BHF CUTS INTERNATIONAL CONSOLIDATED AIRLINES GROUP TO 'NEUTRAL' (BUY) - PRICE TARGET 2.80 (3.50) EUR

----------

LIBERUM CUTS RIGHTMOVE PRICE TARGET TO 470 (570) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BT GROUP PRICE TARGET TO 110 (146) PENCE - 'SELL'

----------

DEUTSCHE BANK RAISES COMPASS GROUP PRICE TARGET TO 1506 (1200) PENCE - 'HOLD'

----------

HSBC CUTS SEGRO PRICE TARGET TO 833 (890) PENCE - 'HOLD'

----------

HSBC CUTS LAND SECURITIES PRICE TARGET TO 679 (897) PENCE - 'HOLD'

----------

JPMORGAN CUTS LAND SECURITIES PRICE TARGET TO 685 (775) PENCE - 'NEUTRAL'

----------

HSBC CUTS BRITISH LAND CO TO 'HOLD' ('BUY') - TARGET 385 (643) PENCE

----------

JPMORGAN CUTS BRITISH LAND CO PRICE TARGET TO 460 (490) PENCE - 'NEUTRAL'

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6690 (6450) PENCE - 'REDUCE'

----------

CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 9000 (8500) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1550 (1450) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 820 (850) PENCE - 'BUY'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4730 (4870) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES POLYMETAL PRICE TARGET TO 1800 (1500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLENCORE PRICE TARGET TO 170 (140) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS FRESNILLO PRICE TARGET TO 550 (600) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BHP PRICE TARGET TO 1830 (1820) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ANTOFAGASTA PRICE TARGET TO 700 (660) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ANGLO AMERICAN PRICE TARGET TO 2500 (2300) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS INTERTEK PRICE TARGET TO 4400 (4550) PENCE - 'NEUTRAL'

----------

SHORE CAPITAL RESUMES J SAINSBURY WITH 'HOLD'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 3522 (3998) PENCE

----------

JEFFERIES CUTS NEXT PRICE TARGET TO 5600 (6700) PENCE - 'HOLD'

----------

JPMORGAN RAISES WPP PRICE TARGET TO 750 (630) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('NEUTRAL') TARGET 340(490)P

----------

JPMORGAN CUTS MARSTONS PRICE TARGET TO 57 (128) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS JD WETHERSPOON PRICE TARGET TO 600 (1100) PENCE - 'UNDERWEIGHT'

----------

CITIGROUP CUTS TUI PRICE TARGET TO 125 (260) PENCE - 'SELL'

----------

PEEL HUNT CUTS GENUS TO 'HOLD' ('BUY')

----------

DEUTSCHE BANK RAISES IMI PRICE TARGET TO 1000 (940) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SYNTHOMER PRICE TARGET TO 300 (265) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 317 (274) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES ELEMENTIS PRICE TARGET TO 100 (75) PENCE - 'BUY'

----------

BERENBERG RAISES PLUS500 PRICE TARGET TO 1120 (1033) PENCE - 'HOLD'

----------

BARCLAYS CUTS WEIR GROUP PRICE TARGET TO 1200 (1750) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 400 (550) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 170 (160) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERREXPO PRICE TARGET TO 130 (190) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS WORKSPACE PRICE TARGET TO 930 (980) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS GREAT PORTLAND PRICE TARGET TO 660 (825) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS DERWENT LONDON PRICE TARGET TO 2850 (3720) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES IP GROUP TO 'BUY' ('HOLD') - TARGET 73 (72) PENCE

----------

INVESTEC RAISES KINGFISHER TO 'HOLD' ('SELL') - TARGET 160 (170) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES RESTAURANT GROUP TO 'BUY' ('NEUTRAL')

----------

RBC CUTS HURRICANE ENERGY PRICE TARGET TO 30 (65) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS YOUNG & COS BREWERY PRICE TARGET TO 1230 (1550) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PETRA DIAMONDS PRICE TARGET TO 5 (6) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS GEM DIAMONDS PRICE TARGET TO 40 (50) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HELICAL PRICE TARGET TO 435 (475) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS DRAPER ESPRIT PRICE TARGET TO 487 (727) PENCE - 'BUY'

----------

JEFFERIES CUTS ALLIED MINDS PRICE TARGET TO 56 (99) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.